Pharmaceutical Technology

MARCH 30, 2023

The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.

Contract Manufacturing 147

Contract Manufacturing Manufacturing Pharma Companies Cosmetics 147

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Capturing market share. billion by 2026, according to research by the Business Research Company.

Marketing 98

Marketing Life Science Sales Branding 98

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies. Outside of pharma, the list included new ads from Revlon and mobile games Dream.

Drugs 105

Drugs Allergies Branding FDA Approval 105

Drug Discovery World

MAY 6, 2024

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. respectively compared to an average market growth of 5.8%

Drugs 57

Drugs Life Science Gene Editing Gene 57

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. Cailiff’s answer was circumspect.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

World of DTC Marketing

MARCH 24, 2022

I’ve seen some new energy and thinking taking root in some big pharma companies. Still, I’m also seeing some recycled executives show up at other companies when they should have been removed permanently from the industry. John worked for a division of a major pharma company in Cambridge.

Pharma Companies 213

Pharma Companies HR Sales Regulation 213

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 130

Branding Marketing Pharma Companies Life Science 130

BioPharma Reporter

AUGUST 31, 2023

The moment that major pharma companies have been dreading, since the approval of Biden's Inflation Reduction Act, has arrived.

Pharma Companies 97

Pharma Companies Drugs Regulation Marketing 97

Drug Discovery World

FEBRUARY 6, 2024

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. Quris-AI, which combines patient-on-a-chip, AI and real-time nano-sensing technologies to predict the safety and efficacy of drug candidates.

Marketing 67

Marketing Medicine Genome Genomics 67

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data.

Drugs 52

Drugs Marketing Life Science Regulation 52

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. Read below for a preview! .

Drugs 105

Drugs Pharma Companies Licensing Licensing 105

Pharma Marketing Network

OCTOBER 28, 2023

It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients. What is Patient-Centricity?

Pharma Companies 52

Pharma Companies Marketing Development Sales 52

pharmaphorum

DECEMBER 21, 2021

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene. Pharma companies are looking at whether blocking TIGIT as well as PD-1/PD-L1 can improve the efficacy of cancer immunotherapy.

Drugs 98

Drugs Antibody Pharma Companies Development 98

World of DTC Marketing

FEBRUARY 28, 2021

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties.

Vaccination 180

Vaccination Vaccine Contamination Compliance 180

Fossil Remedies

OCTOBER 16, 2022

When you launch a PCD pharma company , you have to do several preparations. In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies. Retail Drug License.

Licensing 52

Licensing Licensing Pharma Companies Cosmetics 52

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Dermatology 118

Dermatology Production Pharma Companies Marketing 118

World of DTC Marketing

FEBRUARY 16, 2022

What is pharma’s responsibility? Pharma provides medications to treat everything from severe cardiac issues to depression but should America’s pharma companies go beyond just providing a treatment? People accuse pharma of keeping people sick to make money. Pha a fails in this. That’s a rumor.

Pharma Companies 178

Pharma Companies Regulation Vaccination Vaccine 178

pharmaphorum

JUNE 2, 2022

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. This is why the action by the US in 1983 and subsequently the European Commission Regulation No. It is estimated that between 3.5 The price is right.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

SEPTEMBER 30, 2021

The new guidance is the first of a series that have been promised by the US regulator to develop a framework for regulating RWD, which is increasingly being used by pharma companies to investigate how their medicines perform beyond the controlled environment of clinical trials.

Pharma Companies 95

Pharma Companies Regulation Clinical Trials Clinical Trials 95

BioPharma Reporter

FEBRUARY 18, 2021

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Pharma Companies 52

Pharma Companies Development Manufacturing Drugs 52

pharmaphorum

AUGUST 2, 2022

Roche’s Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in a phase 3 trial. Also coming through is Pfizer, which partners with Germany’s Merck KGaA on latecomer PD-L1 drug Bavencio (avelumab).

Trials 105

Trials Marketing Drugs Pharma Companies 105

World of DTC Marketing

JUNE 24, 2021

Safety pages on Pharma product websites continue to have high utility. As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. Prescription drugs are not the same as items found in a grocery store. ” They go online to learn more.

Doctors 165

Doctors Doctor Production Drugs 165

pharmaphorum

JULY 28, 2022

The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. Many of the medicines most badly affected by these shortages are generic drugs to treat common conditions such as diabetes and heart disease.

Compliance 111

Compliance Drugs Manufacturing Generic Drugs 111

Camargo

NOVEMBER 11, 2020

When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely. Presumably, Antares’ long-established 90-person urology sales force can achieve pull-thru of this drug product.

Development 242

Development Bioequivalency Generic Drugs Production 242

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”.

Marketing 105

Marketing Drugs Regulation Development 105

pharmaphorum

DECEMBER 21, 2021

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs. Headway being made. The potential to leverage genomic data.

Development 98

Development Genome Genomics Drugs 98

pharmaphorum

NOVEMBER 4, 2020

As an influential panel of FDA-appointed experts prepares its verdict on Biogen’s Alzheimer’s drug, a little known China-based pharma is hoping to succeed where big name rivals have failed and develop a drug that is effective against the disease.

Trials 74

Trials Drugs Bacteria Pharma Companies 74

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Then there is the cost of generic drugs.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

Delveinsight

FEBRUARY 14, 2021

Caretakers and families of patients shell out thousands of dollars yearly to buy orphan drugs, as designated by the USFDA. Pharmaceutical companies sell their orphan drugs at astronomical prices such that many patients are not able to afford them. However unfortunate this is, it can be understood.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

XTalks

MARCH 28, 2024

Italy-based drugmaker Italfarmaco has won US Food and Drug Administration (FDA) approval for its oral medication Duvyzat (givinostat) for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and older. The drug generated domestic sales of $200.4 million last year, of which $131.3

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

JULY 15, 2021

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma companies accused of colluding to hike the price of medicines delivered to the NHS. The regulator says that the in addition to the fines, the NHS may choose to pursue the companies for damages in the courts.

Marketing 119

Marketing Sales Pharma Companies Medicine 119

Delveinsight

AUGUST 17, 2020

The Gastroparesis market size in the 7MM was found to be USD 3,170.01 The poor diagnosis rate of the disease is another unmet need prevailing in the Gastroparesis market. However, for moderate-to-severe cases, medications exist in the gastroparesis market that proffers relief.

Marketing 54

Marketing FDA Approval Trials Clinical Development 54

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. However, to invest in drug development for this condition, a number of methodological issues will need to be addressed.

Development 98

Development Drugs Clinical Trials Clinical Trials 98

pharmaphorum

AUGUST 21, 2020

Here we highlight the biggest R&D, market access and digital coronavirus news of the past week. Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an early-stage trial.

Vaccination 105

Vaccination Vaccine Regulation Manufacturing 105

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. We have also seen the regulators actively support the use of these hybrid decentralised research approaches. Each device type has an important role to play in hybrid and DCT trials.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

Camargo

MARCH 9, 2021

The FDA revealed that pharma companies are not forthcoming when they publicly disclose the reasons behind a refuse-to-file (RTF) letter from the Agency. In fact, when they do disclose their existence, companies disclosed only 5% of the reasons for the RTF. in 2020) Keytruda. FDA Inspection Delays During the Pandemic, Continued.

Development 146

Development Manufacturing Drugs Production 146

pharmaphorum

JANUARY 8, 2021

There’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Switzerland’s Arvelle Therapeutics in a deal worth up to $960 million based around the anti-seizure drug cenobamate. It is a small molecule with a dual action, which stimulates the ?-aminobutyric

Licensing 52

Licensing Licensing Pharma Companies Branding 52